Coca-Cola Europacific
CCEP
100.86
-0.85
-0.84%
Coca-Cola Europacific
US · CCEP
#492 by market cap
Listed 1970
100.86
-0.85
-0.84%
Live - 5344 symbols - heartbeat 103s ago
· 2026-10-08 04:26
Pre-market
101.30
+0.44%
After-hours
100.86
0.00%
Overnight
100.97
+0.11%
- Market cap
- 44.34B
- P/E (TTM)i
- 20.29
- P/Bi
- 4.78
- EPSi
- 4.77
- Div yieldi
- 2.35%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on CCEP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.59, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.27% YoY
Margins
- Gross margin
- 35.60%
- Operating margin
- 13.36%
- Net margin
- 9.29%
Key ratios & quality
- Enterprise valuei
- 53.55B
- PEG ratioi
- 2.31
- Altman Z-Scorei
- 2.59
PEG uses trailing P/E against the 3-year net income growth rate (8.80%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.52B | 12.02B | 10.61B | 13.76B | 17.32B | 18.30B | 20.44B | 20.90B |
| Gross profit | 4.46B | 4.59B | 3.74B | 5.09B | 6.22B | 6.72B | 7.21B | 7.44B |
| Selling & admin expenses | 3.16B | 3.05B | 1.15B | 1.54B | 1.99B | 2.20B | 2.35B | 2.35B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.30B | 1.55B | 1.13B | 1.70B | 2.23B | 2.33B | 2.54B | 2.79B |
| Pretax profit | 1.21B | 1.45B | 695.00M | 1.38B | 1.96B | 2.20B | 1.94B | 2.57B |
| Tax | 296.00M | 364.00M | 197.00M | 394.00M | 436.00M | 534.00M | 492.00M | 590.00M |
| Net profit | 909.00M | 1.09B | 498.00M | 988.00M | 1.52B | 1.67B | 1.44B | 1.98B |
| Basic EPS | 2 | 2 | 1 | 2 | 3 | 4 | 3 | 4 |
| Diluted EPS | 1.86 | 2.32 | 1.09 | 2.15 | 3.29 | 3.63 | 3.08 | 4.26 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -- | -- | -- | -- | -- | -- |
| Pretax profit | -- | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -- | -- | -- | -- | -- | -- |
| Basic EPS | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.99B | 3.10B | 4.08B | 5.76B | 6.54B | 6.61B | 6.64B | 6.08B |
| Cash & ST investments | 309.00M | 316.00M | 1.52B | 1.47B | 1.64B | 1.99B | 1.71B | 957.00M |
| Inventory | 693.00M | 723.00M | 681.00M | 1.16B | 1.38B | 1.36B | 1.61B | 1.55B |
| Total assets | 18.22B | 18.69B | 19.24B | 29.09B | 29.31B | 29.25B | 31.10B | 29.87B |
| Total current liabilities | 3.79B | 4.12B | 4.14B | 6.09B | 7.31B | 7.28B | 8.15B | 7.59B |
| Short-term debt | 491.00M | 799.00M | 805.00M | 1.35B | 1.34B | 1.30B | 1.39B | 470.00M |
| Long-term debt | 5.07B | 5.35B | 6.11B | 11.28B | 10.04B | 9.55B | 9.39B | 9.69B |
| Total liabilities | 11,652,000,000.00 | 12,529,000,000.00 | 13,212,000,000.00 | 21,880,000,000.00 | 21,866,000,000.00 | 21,278,000,000.00 | 22,115,000,000.00 | 21,569,000,000.00 |
| Total equity | 6.56B | 6.16B | 6.03B | 7.21B | 7.45B | 7.98B | 8.99B | 8.30B |
| Retained earnings | 6.67B | 6.14B | 6.08B | 6.68B | 7.43B | 8.23B | 8.80B | 8.82B |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 6.61B | 7.52B | 6.64B | 8.08B | 6.08B | 8.32B |
| Cash & ST investments | 1.99B | 1.88B | 1.71B | 2.06B | 957.00M | 1.99B |
| Inventory | 1.36B | 1.91B | 1.61B | 1.81B | 1.55B | 1.92B |
| Total assets | 29.25B | 32.10B | 31.10B | 31.79B | 29.87B | 32.48B |
| Total current liabilities | 7.28B | 8.88B | 8.15B | 9.69B | 7.59B | 9.36B |
| Short-term debt | 1.30B | 2.02B | 1.39B | 2.26B | 470.00M | 1.66B |
| Long-term debt | 9.55B | 9.58B | 9.39B | 9.22B | 9.69B | 10.03B |
| Total liabilities | 21,278,000,000.00 | 23,092,000,000.00 | 22,115,000,000.00 | 23,281,000,000.00 | 21,569,000,000.00 | 23,716,000,000.00 |
| Total equity | 7.98B | 9.01B | 8.99B | 8.51B | 8.30B | 8.77B |
| Retained earnings | 8.23B | 8.72B | 8.80B | 8.95B | 8.82B | 8.94B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.81B | 1.90B | 1.49B | 2.12B | 2.93B | 2.81B | 3.06B | 2.95B |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | -- | -- |
| Free cash flow | 1.21B | 1.30B | 1.08B | 1.67B | 2.33B | 1.99B | 2.12B | 2.00B |
| Dividends paid | -513.00M | -574.00M | -386.00M | -638.00M | -763.00M | -841.00M | -910.00M | -927.00M |
| Stock buybacks / issuance | -477.00M | -979.00M | -115.00M | 28.00M | 13.00M | 43.00M | 31.00M | -1.05B |
| Ending cash balance | 309.00M | 316.00M | 1.52B | 1.41B | 1.39B | 1.42B | 1.56B | 918.00M |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 13.72 | 17.14 | 8.18 | 15.04 | 20.83 | 21.64 | 17.22 | 23.79 |
| ROA %i | 4.99 | 5.91 | 2.63 | 4.06 | 5.16 | 5.70 | 4.70 | 6.37 |
| ROIC %i | 7.92 | 9.34 | 4.48 | 6.35 | 8.08 | 9.00 | 7.83 | 10.82 |
| 5-year avg ROE %i | 24.63 | 21.23 | 12.90 | 12.91 | 14.98 | 16.57 | 16.58 | 19.71 |
| EBIT margin %i | 11.63 | 13.24 | 7.80 | 11.15 | 12.06 | 12.92 | 10.66 | 13.60 |
| FCF / sales %i | 10.47 | 10.83 | 10.20 | 12.14 | 13.45 | 10.90 | 10.38 | 9.58 |
| Current ratioi | 0.79 | 0.75 | 0.98 | 0.95 | 0.89 | 0.91 | 0.81 | 0.80 |
| Quick ratioi | 0.58 | 0.54 | 0.78 | 0.67 | 0.60 | 0.66 | 0.56 | 0.52 |
| Debt / assetsi | 30.84 | 34.36 | 37.36 | 45.17 | 40.62 | 38.96 | 36.43 | 35.80 |
| LT debt / equityi | 78.11 | 91.33 | 105.93 | 167.64 | 141.95 | 126.58 | 117.09 | 130.49 |
| Interest coveragei | 9.99 | 11.61 | 6.27 | 10.03 | 15.94 | 14.60 | 9.00 | 10.38 |
| Revenue CAGR (3Y) %i | 22.09 | 9.58 | -1.39 | 6.12 | 12.96 | 19.95 | 14.09 | 6.46 |
| Net income CAGR (3Y) %i | 21.01 | 25.69 | -10.21 | 2.61 | 11.43 | 49.65 | 13.03 | 8.80 |
| FCF CAGR (3Y) %i | 25.58 | 20.35 | -0.64 | 11.48 | 21.39 | 22.60 | 8.29 | -4.90 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 21.64 | 19.80 | 17.22 | 18.53 | 23.79 | 24.48 |
| ROA %i | 5.70 | 5.21 | 4.70 | 4.80 | 6.37 | 6.21 |
| ROIC %i | 9.00 | 8.48 | 7.83 | 8.14 | 10.82 | 10.58 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.92 | 12.24 | 10.66 | 11.47 | 13.60 | 13.76 |
| FCF / sales %i | 10.90 | 8.78 | 10.38 | 9.52 | 9.58 | 9.61 |
| Current ratioi | 0.91 | 0.85 | 0.81 | 0.83 | 0.80 | 0.89 |
| Quick ratioi | 0.66 | 0.56 | 0.56 | 0.56 | 0.52 | 0.59 |
| Debt / assetsi | 38.96 | 37.86 | 36.43 | 37.79 | 35.80 | 37.53 |
| LT debt / equityi | 126.58 | 118.82 | 117.09 | 121.51 | 130.49 | 127.16 |
| Interest coveragei | 14.60 | 11.90 | 9.00 | 9.78 | 10.38 | 10.13 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Making, selling and distributing an extensive range of primarily non-alcoholic ready to drink100.00%
Region
Great Britain16.60%
Iberia16.41%
Germany15.32%
France11.67%
Australia11.29%
Philippines9.04%
Other7.33%
Belgium/Luxembourg5.18%
Netherlands3.99%
New Zealand and Pacific Islands3.17%
Quote time 2026-10-08 04:26:39 · For reference only, not investment advice and not tailored to your situation.